Results 71 to 80 of about 30,626 (259)
Ileocolonic mucormycosis in adult immunocompromised patients: A surgeon's perspective [PDF]
, 2010 We report three cases of ileocolic mucormycosis in adult immunocompromised patients presenting as acute abdomen. All patients underwent laparotomy but two of them died from multiorgan failure before the diagnoses were confirmed.
Law, WL, Lo, OSH
core +2 more sources
Journal of Diabetes Research, Volume 2026, Issue 1, 2026.Aims This retrospective study is aimed at evaluating the effect of SGLT2 inhibitors (SGLT2i) on the risk of sepsis among patients with Type 2 diabetes mellitus (T2DM). Materials and Methods An active‐comparator new user design was utilized based on Taiwan′s National Health Insurance Research Database. Adult patients diagnosed with T2DM between 2017 and
Chun-Ying Wu +8 more
wiley +1 more source
Practice Guideline on Prevention, Diagnosis, and Treatment of Rhino-Orbito-Cerebral Mucormycosis in the COVID-19 Area: A Consensus of Iranian Experts [PDF]
, 2022 Farzad Pakdel +5 more
openalex +1 more source
Journal of Acute Disease, 2022 Objective: To explore risk factors of mucormycosis in COVID-19 recovered patients. Methods: A total of 101 patients, who were diagnosed with mucormycosis after recovery from COVID-19 and admitted to the Indira Gandhi Institute of Medical Sciences, Patna,
Praphull Deepankar +3 more
doaj +1 more source
Galactomannan and 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Aspergillosis [PDF]
, 2016 Invasive aspergillosis (IA) is a severe complication among hematopoietic stem cell transplant recipients or patients with hematological malignancies and neutropenia following anti-cancer therapy. Moreover, IA is increasingly observed in other populations,
Lamoth, Frédéric
core +2 more sources
Mucormycosis in a patient with COVID-19 with uncontrolled diabetes [PDF]
, 2021 Muhammad Shakir +2 more
openalex +1 more source
Transdiaphragmatic Mucormycosis
Clinical Infectious Diseases, 2019 Abstract Mucormycosis is a life-threatening infection. This is the first report of transdiaphragmatic mucormycosis in a series of 3 patients. We observed this phenomenon in 11% of patients. Clinicians should be aware of this possibly underreported entity, and as a consequence we envision more comprehensive imaging studies in patients ...
Philipp Koehler +4 more
openaire +2 more sources
Clinical Pharmacology &Therapeutics, Volume 118, Issue 6, Page 1405-1421, December 2025.Several regulatory initiatives have been made to clarify the acceptability and requirements of real‐world data and real‐world evidence (RWD/E) for the benefit/risk assessment of new medical products in Japan. The objectives of this review were to characterize the use of RWD/E in regulatory applications of new medical products and to describe the ...
Suguru Okami +2 more
wiley +1 more source
Can Intravenous Antifungal therapy be safely used in the Outpatient Parenteral Antimicrobial Therapy (OPAT) setting? [PDF]
, 2019 Outpatient parenteral antimicrobial therapy (OPAT) is an established treatment option for patients with a variety of infections who require a period of intravenous therapy, are clinically stable, and do not require continuous monitoring.
Kenny, Claire +2 more
core +2 more sources
Journal of British Surgery, 1991 Abstract Twenty patients with gastrointestinal mucormycosis are reviewed. This often fatal opportunistic fungal infection was diagnosed histologically, and was categorized as colonization (five patients), infiltration (seven patients), or vascular invasion (eight patients). There were no fatalities from colonization.
S R, Thomson +3 more
openaire +2 more sources